Burning Rock Biotech annual free cash flow
2018
2019
2020
2021
2022
2023
2024
2025
Burning Rock Biotech Free Cash Flow (FCF) History (BNR)
Burning Rock Biotech reported −¥33.7M in free cash flow for fiscal 2025, an increase of ¥64.0M from the previous fiscal year, with a free cash flow margin of −6.24%.
View full Burning Rock Biotech company overviewBurning Rock Biotech free cash flow by year
| Fiscal year | Period ended | Free cash flow | Change | Growth | FCF margin |
|---|---|---|---|---|---|
| 2025 | 2025-12-31 | −¥33.7M | ¥64.0M | — | −6.24% |
| 2024 | 2024-12-31 | −¥97.7M | ¥166.2M | — | −18.94% |
| 2023 | 2023-12-31 | −¥263.9M | ¥255.0M | — | −49.10% |
| 2022 | 2022-12-31 | −¥518.8M | ¥163.4M | — | −92.12% |
| 2021 | 2021-12-31 | −¥682.2M | −¥548.4M | — | −134.33% |
| 2020 | 2020-12-31 | −¥133.8M | ¥137.2M | — | −31.13% |
| 2019 | 2019-12-31 | −¥271.0M | −¥99.0M | — | −71.01% |
| 2018 | 2018-12-31 | −¥172.0M | — | — | −82.33% |
Burning Rock Biotech quarterly free cash flow
No reported data
| Fiscal quarter | Period ended | Free cash flow | Change | YoY growth | FCF margin |
|---|
Burning Rock Biotech free cash flow growth trends
Over the last five reported fiscal years, free cash flow grew from −¥133.8M to −¥33.7M, a net increase of ¥100.1M.
About the metric
What free cash flow means
Free cash flow is the cash a company generates from operations after capital expenditures. Positive FCF can fund dividends, buybacks, debt repayment, or reinvestment; negative FCF means capital spending exceeded operating cash flow for that period.
Calculation and source
How free cash flow is calculated
TickerStat calculates free cash flow as SEC-reported operating cash flow minus capital expenditures. FCF margin equals free cash flow divided by revenue. Fiscal periods can differ from calendar years, so the tables include exact period-end dates.
Review Burning Rock Biotech filings at SEC.gov ↗